The 26th Bio€quity Europe 2026, Prague

Published on 04/05/2026

May 4-6, 2026
Prague, Czech Republic

ENYO Pharma is attending Bio€quity Europe on May 4-6, 2026 in Prague, engaging with venture investors to discuss near and mid term value creation across our kidney disease pipeline to accelerate the clinical advancement of Vonafexor and EYP651 in various kidney diseases.
The main focus during the event will be on the positive Phase 2 ALPESTRIA 1 results in Alport syndrome.